68 related articles for article (PubMed ID: 24800948)
1. Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.
Aparicio T; Henriques J; Svrcek M; Zaanan A; Manfredi S; Casadei-Gardini A; Tougeron D; Gornet JM; Jary M; Terrebonne E; Piessen G; Afchain P; Lecaille C; Pocard M; Lecomte T; Rimini M; Di Fiore F; Le Brun Ly V; Cascinu S; Vernerey D; Laurent Puig P
Br J Cancer; 2024 May; ():. PubMed ID: 38745088
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability: an update.
Yamamoto H; Imai K
Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in
Zaanan A; Bachet JB; André T; Sinicrope FA
Curr Colorectal Cancer Rep; 2014 Sep; 10(3):346-353. PubMed ID: 25386108
[TBL] [Abstract][Full Text] [Related]
4. CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
Shiovitz S; Bertagnolli MM; Renfro LA; Nam E; Foster NR; Dzieciatkowski S; Luo Y; Lao VV; Monnat RJ; Emond MJ; Maizels N; Niedzwiecki D; Goldberg RM; Saltz LB; Venook A; Warren RS; Grady WM;
Gastroenterology; 2014 Sep; 147(3):637-45. PubMed ID: 24859205
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine.
Ye J; Zhang J; Ding W
Explor Target Antitumor Ther; 2024; 5(1):34-53. PubMed ID: 38464391
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Significance of Promoter Methylation of Fluoropyrimidine Metabolizing and Cyclooxygenase Genes in Colorectal Cancer.
Fouad MA; Salem SE; Hussien MM; Badr DM; Zekri AN; Hafez HF; Shouman SA
Epigenet Insights; 2021; 14():2516865720986231. PubMed ID: 33644686
[TBL] [Abstract][Full Text] [Related]
7. Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer.
Nakamura Y; Yokoyama S; Matsuda K; Tamura K; Mitani Y; Iwamoto H; Mizumoto Y; Murakami D; Kitahata Y; Yamaue H
Sci Rep; 2021 Jan; 11(1):441. PubMed ID: 33432066
[TBL] [Abstract][Full Text] [Related]
8. DPD status and fluoropyrimidines-based treatment: high activity matters too.
Chamorey E; Francois E; Etienne MC; Ferrero JM; Peyrade F; Barranger E; Bozec A; Largillier R; Cassuto O; Viotti J; Schiappa R; Milano G
BMC Cancer; 2020 May; 20(1):436. PubMed ID: 32423482
[TBL] [Abstract][Full Text] [Related]
9. Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.
Advani SM; Advani PS; Brown DW; DeSantis SM; Korphaisarn K; VonVille HM; Bressler J; Lopez DS; Davis JS; Daniel CR; Sarshekeh AM; Braithwaite D; Swartz MD; Kopetz S
BMC Cancer; 2019 Oct; 19(1):964. PubMed ID: 31623592
[TBL] [Abstract][Full Text] [Related]
10. TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer.
Ntavatzikos A; Spathis A; Patapis P; Machairas N; Vourli G; Peros G; Papadopoulos I; Panayiotides I; Koumarianou A
World J Gastrointest Oncol; 2019 Jul; 11(7):551-566. PubMed ID: 31367274
[TBL] [Abstract][Full Text] [Related]
11. Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis.
Advani SM; Advani P; DeSantis SM; Brown D; VonVille HM; Lam M; Loree JM; Mehrvarz Sarshekeh A; Bressler J; Lopez DS; Daniel CR; Swartz MD; Kopetz S
Transl Oncol; 2018 Oct; 11(5):1188-1201. PubMed ID: 30071442
[TBL] [Abstract][Full Text] [Related]
12. Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma.
Heby M; Lundgren S; Nodin B; Elebro J; Eberhard J; Jirström K
J Transl Med; 2018 Mar; 16(1):66. PubMed ID: 29540182
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics and Precision Oncology.
Werner RJ; Kelly AD; Issa JJ
Cancer J; 2017; 23(5):262-269. PubMed ID: 28926426
[TBL] [Abstract][Full Text] [Related]
14. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.
Sepulveda AR; Hamilton SR; Allegra CJ; Grody W; Cushman-Vokoun AM; Funkhouser WK; Kopetz SE; Lieu C; Lindor NM; Minsky BD; Monzon FA; Sargent DJ; Singh VM; Willis J; Clark J; Colasacco C; Rumble RB; Temple-Smolkin R; Ventura CB; Nowak JA
J Mol Diagn; 2017 Mar; 19(2):187-225. PubMed ID: 28185757
[TBL] [Abstract][Full Text] [Related]
15. Molecular Biomarkers for the Evaluation of Colorectal Cancer.
Sepulveda AR; Hamilton SR; Allegra CJ; Grody W; Cushman-Vokoun AM; Funkhouser WK; Kopetz SE; Lieu C; Lindor NM; Minsky BD; Monzon FA; Sargent DJ; Singh VM; Willis J; Clark J; Colasacco C; Rumble RB; Temple-Smolkin R; Ventura CB; Nowak JA
Am J Clin Pathol; 2017 Mar; 147(3):221-260. PubMed ID: 28165529
[TBL] [Abstract][Full Text] [Related]
16. Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study.
Etienne-Grimaldi MC; Mahamat A; Chazal M; Laurent-Puig P; Olschwang S; Gaub MP; Formento JL; Formento P; Sudaka A; Boige V; Abderrahim-Ferkoune A; Benchimol D; André T; Houry S; Faucheron JL; Letoublon C; Gilly FN; Delpero JR; Lasser P; Pradere B; Pezet D; Penault-Llorca F; Milano G
Br J Cancer; 2014 May; 110(11):2728-37. PubMed ID: 24800948
[TBL] [Abstract][Full Text] [Related]
17. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
18. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract][Full Text] [Related]
19. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
